Allogene Therapeutics Inc
(NAS:ALLO)
$
2.075
-0.005 (-0.24%)
Market Cap: 436.36 Mil
Enterprise Value: 138.33 Mil
PE Ratio: 0
PB Ratio: 0.77
GF Score: 28/100 - Q1 2024 Allogene Therapeutics Inc Earnings Call TranscriptMay 13, 2024$2.9 (+5.07%)Earnings
- Q4 2023 Allogene Therapeutics Inc Earnings Call TranscriptMar 14, 2024$4.5 (-7.89%)Earnings
- Allogene Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Allogene Therapeutics Inc Platform Vision Call TranscriptJan 04, 2024
- Q3 2023 Allogene Therapeutics Inc Earnings Call TranscriptNov 02, 2023$2.97 (+4.95%)Earnings
- Q2 2023 Allogene Therapeutics Inc Earnings Call TranscriptAug 02, 2023$4.69 (-2.09%)Earnings
- Allogene Therapeutics Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Allogene Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Allogene Therapeutics Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Allogene Therapeutics Inc Earnings Call TranscriptMay 03, 2023$5.72 (+6.92%)Earnings
- Q4 2022 Allogene Therapeutics Inc Earnings Call TranscriptFeb 28, 2023$6.35 (+0.32%)Earnings
- Allogene Therapeutics Inc at B Riley Securities Oncology Conference (Virtual) TranscriptJan 18, 2023
- Allogene Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Allogene Therapeutics Inc R&D Showcase TranscriptNov 29, 2022
- Allogene Therapeutics Inc at Cowen IO Next Summit (Virtual) TranscriptNov 11, 2022
- Q3 2022 Allogene Therapeutics Inc Earnings Call TranscriptNov 02, 2022$10.17 (-3.78%)Earnings
- Q2 2022 Allogene Therapeutics Inc Earnings Call TranscriptAug 09, 2022$15.03 (-5.83%)Earnings
- Allogene Therapeutics Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 13, 2022
- Allogene Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Allogene Therapeutics Inc Earnings Call TranscriptMay 04, 2022$9.43 (+4.31%)Earnings
- Q4 2021 Allogene Therapeutics Inc Earnings Call TranscriptFeb 23, 2022$9.17 (-5.66%)Earnings
- Allogene Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Allogene Therapeutics Inc Business Update Call TranscriptJan 10, 2022
- Allogene Therapeutics Inc to Review ALPHA, ALPHA2 and UNIVERSAL Phase 1 Data Presented at the American Society of Hematology Annual Meeting TranscriptDec 13, 2021
- Q3 2021 Allogene Therapeutics Inc Earnings Call TranscriptNov 04, 2021$19.43 (-3.62%)Earnings
- Allogene Therapeutics Inc Business Update- Conference Call TranscriptOct 07, 2021
- Q2 2021 Allogene Therapeutics Inc Earnings Call TranscriptAug 04, 2021$22.13 (+0.91%)Earnings
- Allogene Therapeutics Inc at Bank of America NAPA Healthcare Conference TranscriptJun 15, 2021
- Allogene Therapeutics Inc Annual Shareholders Meeting TranscriptJun 10, 2021
- Allogene Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- Allogene Therapeutics Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 01, 2021
- Allogene Therapeutics Inc to Host Virtual CD19 Forum TranscriptMay 19, 2021
- Q1 2021 Allogene Therapeutics Inc Earnings Call TranscriptMay 05, 2021$28.71 (-2.31%)Earnings
- Q4 2020 Allogene Therapeutics Inc Earnings Call TranscriptFeb 25, 2021$32.79 (-4.79%)Earnings
- Allogene Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Allogene Therapeutics Inc to Review The Potential Innovation of Allogeneic CAR T Therapy in Multiple Myeloma TranscriptDec 05, 2020
- Q3 2020 Allogene Therapeutics Inc Earnings Call TranscriptNov 04, 2020$31.06 (-8.08%)Earnings
- Allogene Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Q2 2020 Allogene Therapeutics Inc Earnings Call TranscriptAug 05, 2020$38.45 (+3.69%)Earnings
- Allogene Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2020
- Allogene Therapeutics Inc Annual Shareholders Meeting TranscriptJun 05, 2020
- Q1 2020 Allogene Therapeutics Inc Earnings Call TranscriptMay 06, 2020$30.07 (-2.56%)Earnings
- Q4 2019 Allogene Therapeutics Inc Earnings Call TranscriptFeb 27, 2020$25.92 (+1.85%)Earnings
- Allogene Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Q3 2019 Allogene Therapeutics Inc Earnings Call TranscriptNov 05, 2019$27.66 (-4.36%)Earnings
- Allogene Therapeutics Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 Allogene Therapeutics Inc Earnings Call TranscriptAug 07, 2019$29.59 (-0.54%)Earnings
- Q1 2019 Allogene Therapeutics Inc Earnings Call TranscriptMay 07, 2019$29.79 (-4.18%)Earnings
- Q4 2018 Allogene Therapeutics Inc Earnings Call TranscriptMar 08, 2019$28.38 (-4.28%)Earnings
Allogene Therapeutics Inc at Bank of America Global Healthcare Conference Transcript
May 10, 2023 / 11:20PM GMT
Release Date Price:
$6.36
(+2.09%)
Perry Ezra Mayo;Malasky
BofA Securities, Research Division - Research Analyst
So hi, everyone. My name is Perry. Mayo-Malasky. I'm one of the analysts here at Bank of America on Jason Gerberry's team, who covers SMID biotech and specialty pharma. I'm pleased to introduce our next guest, Allogene Therapeutics. I'm here with CFO, Eric Schmidt. Eric, welcome.
Eric Thomas Schmidt
Allogene Therapeutics, Inc. - Executive VP & CFO
Perry, thanks so much for having us here. I remember last year, this was sort of the first coming-out party on Wall Street post-COVID. And today, it's just been a pleasure to see the activity in the hallways and elevator banks and feel like really the world is back to life. So terrific opportunity for us.
Perry Ezra Mayo;Malasky
BofA Securities, Research Division - Research Analyst
Yes, absolutely. And it's great to be here in person.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)